Works matching AU Soo Yoon Sung


Results: 273
    1
    2

    Pathologic Staging Inconsistency Between ypT4N0 (stage II) and ypT1-2N1 (stage III) After Preoperative Chemoradiotherapy and Total Mesorectal Excision in Rectal Cancer: A Multi-Institutional Study.

    Published in:
    2019
    By:
    • Joo Hwan Lee;
    • Mina Yu;
    • Sung Hwan Kim;
    • Jong Hoon Lee;
    • Soo-Yoon Sung;
    • Bae Kwon Jeong;
    • Songmi Jeong;
    • Taek Keun Nam;
    • Jae Uk Jeong;
    • Hong Seok Jang;
    • Lee, Joo Hwan;
    • Yu, Mina;
    • Kim, Sung Hwan;
    • Lee, Jong Hoon;
    • Sung, Soo-Yoon;
    • Jeong, Bae Kwon;
    • Jeong, Songmi;
    • Nam, Taek Keun;
    • Jeong, Jae Uk;
    • Jang, Hong Seok
    Publication type:
    journal article
    3
    4

    Hematologic and molecular responses to ropeginterferon alfa‐2b therapy of polycythemia vera: 48‐week results from a prospective study.

    Published in:
    International Journal of Cancer, 2025, v. 157, n. 3, p. 526, doi. 10.1002/ijc.35411
    By:
    • Yoon, Seug Yun;
    • Yoon, Sung‐Soo;
    • Yang, Deok‐Hwan;
    • Lee, Gyeong‐Won;
    • Sohn, Sang Kyun;
    • Shin, Ho‐Jin;
    • Bae, Sung Hwa;
    • Choi, Chul Won;
    • Choi, Eun‐Ji;
    • Cheong, June‐Won;
    • Bang, Soo‐Mee;
    • Park, Joon Seong;
    • Oh, Suk Joong;
    • Park, Yong;
    • Park, Young Hoon;
    • Lee, Sung‐Eun
    Publication type:
    Article
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15

    Patterns of care for patients with nasopharyngeal carcinoma (KROG 11-06) in South Korea.

    Published in:
    Radiation Oncology Journal, 2015, v. 33, n. 3, p. 188, doi. 10.3857/roj.2015.33.3.188
    By:
    • Soo Yoon Sung;
    • Min Kyu Kang;
    • Chul Seung Kay;
    • Ki Chang Keum;
    • Sung Hwan Kim;
    • Yeon-Sil Kim;
    • Won Taek Kim;
    • Ji-Yoon Kim;
    • Jin-Hee Kim;
    • Sung Ho Moon;
    • Yong Chan Ahn;
    • Young Taek Oh;
    • Hong-Gyun Wu;
    • Chang-Geol Lee;
    • Woong-Ki Chung;
    • Kwan Ho Cho;
    • Moon-June Cho;
    • Jin Hwa Choi
    Publication type:
    Article
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30

    Changes in Osteoblastic Activity in Patient Who Received Bortezomib as Second Line Treatment for Plasma Cell Myeloma: A Prospective Multicenter Study.

    Published in:
    BioMed Research International, 2014, v. 2014, p. 1, doi. 10.1155/2014/245247
    By:
    • Ki-Seong Eom;
    • Seok Jin Kim;
    • Je-Jung Lee;
    • Cheolwon Suh;
    • Jin Seok Kim;
    • Sung-Soo Yoon;
    • Byung Soo Kim;
    • Hye Jin Kang;
    • Young Jin Choi;
    • Chul Soo Kim;
    • Yang Soo Kim;
    • Jae-Yong Kwak;
    • Yoo Jin Kim;
    • Young Don Joo;
    • Yeung-Chul Mun;
    • Deog Yeon Jo;
    • Joon Seong Park;
    • Chi-Young Park;
    • Sung-Hyun Kim;
    • Chang-Ki Min
    Publication type:
    Article
    31
    32
    33
    34

    Immunogenomic pan-cancer landscape reveals immune escape mechanisms and immunoediting histories.

    Published in:
    Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-95287-x
    By:
    • Mizuno, Shinichi;
    • Yamaguchi, Rui;
    • Hasegawa, Takanori;
    • Hayashi, Shuto;
    • Fujita, Masashi;
    • Zhang, Fan;
    • Koh, Youngil;
    • Lee, Su-Yeon;
    • Yoon, Sung-Soo;
    • Shimizu, Eigo;
    • Komura, Mitsuhiro;
    • Fujimoto, Akihiro;
    • Nagai, Momoko;
    • Kato, Mamoru;
    • Liang, Han;
    • Miyano, Satoru;
    • Zhang, Zemin;
    • Nakagawa, Hidewaki;
    • Imoto, Seiya
    Publication type:
    Article
    35
    36
    37
    38
    39
    40

    Comprehensive clinico‐genetic analysis reveals prognostic factors of blastic plasmacytoid dendritic cell neoplasm.

    Published in:
    British Journal of Haematology, 2025, v. 206, n. 4, p. 1228, doi. 10.1111/bjh.20022
    By:
    • Lee, Ji Hyun;
    • Oh, Sung‐Yong;
    • Lee, Taek Gyu;
    • Lee, Seung‐Tae;
    • Kim, Namhee;
    • Pak, Min Gyoung;
    • Yoon, Sung‐Soo;
    • Koh, Youngil;
    • Byun, Ja Min;
    • Yoon, Dok Hyun;
    • Jo, Jae‐Cheol;
    • Yang, Deok‐Hwan;
    • Ahn, Seo‐Yeon;
    • Eom, Hyeon Seok;
    • Lee, Hyewon;
    • Lee, Ji Yun;
    • Won, Jong Ho;
    • Yhim, Ho‐Young;
    • Lee, Ho Sup;
    • Kim, Won Seog
    Publication type:
    Article
    41
    42
    43
    44
    45

    Health‐related quality of life in patients with relapsed or refractory multiple myeloma: treatment with daratumumab, lenalidomide, and dexamethasone in the phase 3 POLLUX trial.

    Published in:
    British Journal of Haematology, 2021, v. 194, n. 1, p. 132, doi. 10.1111/bjh.17435
    By:
    • Plesner, Torben;
    • Dimopoulos, Meletios A.;
    • Oriol, Albert;
    • San‐Miguel, Jesus;
    • Bahlis, Nizar J.;
    • Rabin, Neil;
    • Suzuki, Kenshi;
    • Yoon, Sung‐Soo;
    • Ben‐Yehuda, Dina;
    • Cook, Gordon;
    • Goldschmidt, Hartmut;
    • Grosicki, Sebastian;
    • Qin, Xiang;
    • Fastenau, John;
    • Garvin, Wendy;
    • Carson, Robin;
    • Renaud, Thomas;
    • Gries, Katharine S.
    Publication type:
    Article
    46
    47
    48
    49
    50

    Busulfan plus melphalan versus high-dose melphalan as a conditioning regimen for autologous stem cell transplantation in multiple myeloma with high-risk features (KMM 2015).

    Published in:
    Annals of Hematology, 2023, v. 102, n. 8, p. 2233, doi. 10.1007/s00277-023-05308-0
    By:
    • Kim, Mihee;
    • Lee, Je-Jung;
    • Min, Chang-Ki;
    • Lee, Ji Yun;
    • Jo, Jae-Cheol;
    • Yoon, Sung-Soo;
    • Lim, Sung-Nam;
    • Do, Young Rok;
    • Kim, Kihyun;
    • Lee, Jae Hoon;
    • Yoo, Kwai Han;
    • Bae, Sung Hwa;
    • Yi, Jun Ho;
    • Jung, Jongheon;
    • Eom, Hyeon-Seok;
    • Jung, Sung-Hoon
    Publication type:
    Article